Filed Pursuant to Rule 424(b)(5)
Registration No. 333-289636
PROSPECTUS SUPPLEMENT
(To Prospectus dated August 15, 2025)
Prologis, Inc.
Up to $5,000,000,000 Aggregate Offering Price of Common Stock
On October 30, 2026, we and our Operating Partnership entered into an equity distribution agreement (as may be amended from time to time, the “equity distribution agreement”) with Academy Securities, Inc., BBVA Securities Inc., BNP Paribas Securities Corp., BNY Mellon Capital Markets, LLC (acting through Academy Securities, Inc., as its sales agent), BofA Securities, Inc., BTIG, LLC, Citigroup Global Markets Inc., Credit Agricole Securities (USA) Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc., ING Financial Markets LLC, Jefferies LLC, J.P. Morgan Securities LLC, Loop Capital Markets LLC, Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, MUFG Securities Americas Inc., Nomura Securities International, Inc. (acting through BTIG, LLC, as its sales agent), RBC Capital Markets, LLC, Regions Securities LLC, Samuel A. Ramirez & Company, Inc., Santander US Capital Markets LLC, Scotia Capital (USA) Inc., SMBC Nikko Securities America, Inc., TD Securities (USA) LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC, as our sales agents (each a “manager” and together, the “managers”), and, if applicable, the relevant forward sellers and forward purchasers (each, as defined below), relating to the sale of shares of our common stock, $0.01 par value per share (“common stock”) having an aggregate offering price of up to $5,000,000,000, to be made from time to time under this prospectus supplement and the accompanying prospectus through the managers, as our sales agents or the forward sellers, or directly to the managers, as principals for their own accounts.
Our common stock is listed on the New York Stock Exchange, or NYSE, under the symbol “PLD.” The last reported sale price of our common stock on the NYSE on October 29, 2026 was $128.02 per share.
Sales of shares of our common stock, if any, under this prospectus supplement and the accompanying prospectus may be made in negotiated transactions or transactions that are deemed to be “at the market” offerings as defined in Rule 415 under the Securities Act of 1933, as amended, or the Securities Act, including sales made directly on the NYSE or sales made to or through a market maker other than on an exchange, in block transactions, in privately negotiated transactions or as otherwise agreed with the managers. The managers and the forward sellers will make all sales using reasonable efforts, consistent with their normal trading and sales practices and applicable law and regulations, on mutually agreed terms between us and the managers or the forward sellers and the forward purchasers, as applicable. The offering of the shares by the managers and the forward sellers is subject to receipt and acceptance and subject to their right to reject any order in whole or in part.
The equity distribution agreement contemplates that, in addition to the issuance and sale by us of shares of our common stock to or through the managers, we may enter into separate forward sale agreements with each of Banco Bilbao Vizcaya Argentaria, S.A., BNP Paribas, Bank of America, N.A., Citibank, N.A., Crédit Agricole Corporate and Investment Bank, Goldman Sachs & Co. LLC, HSBC Bank USA, National Association, Jefferies LLC, JPMorgan Chase Bank, National Association, Mizuho Markets Americas LLC, Morgan Stanley & Co. LLC, MUFG Securities EMEA plc, Nomura Global Financial Products, Inc., Royal Bank of Canada, Regions Securities LLC, Banco Santander, S.A., The Bank of New York Mellon, The Bank of Nova Scotia, The Toronto-Dominion Bank, Truist Bank and Wells Fargo Bank, National Association, or one of their respective affiliates (in such capacity, each a “forward purchaser” and, collectively, the “forward purchasers”).
If we enter into a forward sale agreement with any forward purchaser, we expect that such forward purchaser (or its affiliates) will attempt to borrow from third parties and sell, through the relevant forward seller, acting as sales agent for such forward purchaser, shares of our common stock to hedge such forward purchaser’s exposure under such forward sale agreement. A “forward seller” is a manager, acting as a sales agent for a particular forward purchaser (which will be an affiliate of such manager or the same entity as such manager) (other than in the cases of BNY Mellon Capital Markets, LLC acting through Academy Securities, Inc., as its sales agent and Nomura Securities International, Inc., acting through BTIG, LLC as its sales agent). Unless otherwise expressly stated or the context otherwise requires, references herein to the “related,” “applicable” or “relevant” forward purchaser mean, with respect to a particular forward seller, the forward purchaser for which such forward seller is acting as sales agent. We will not receive any proceeds from any sale of shares of our common stock borrowed by a forward purchaser (or its affiliates) and sold through a forward seller, but we may receive contingency premiums from the applicable forward purchaser for the contingent forward transactions described below.
In one form of forward sale agreement, which we refer to as a “contingent forward transaction,” our obligation to sell and the applicable forward purchaser’s obligation to purchase shares of our common stock underlying such forward sale agreement at the applicable forward sale price, are contingent on the applicable forward purchaser’s exercise (or deemed exercise) of such contingency, which may occur in whole or in part from time to time prior to specified contingency expiration dates. We refer to such forward purchaser when acting in such capacity as the “contingent forward purchaser.” To the extent a contingency is exercised with respect to a contingent forward transaction, we refer to the portion of such contingent forward transaction as the “contingency exercised portion,” and the remaining portion to the extent that such contingency is not yet exercised but may be exercised as the “contingent portion.” We expect that the initial forward price of the contingent forward transactions will be above, but not substantially above, the volume-weighted average sale price per share at which the applicable forward seller established its hedge position in respect of such contingent forward transaction (the “contingent forward initial hedge position”). In addition, we expect that on the same days when the contingent forward purchaser is so selling shares of our common stock underlying such contingent forward transaction, through such forward seller, the contingent forward purchaser will contemporaneously purchase a substantial portion of such number of shares in the open market for its own account to offset such number of shares sold into the market, as the contingent forward purchaser expects its contingent forward initial hedge position to be substantially less than the number of shares of our common stock underlying such forward sale agreement.
In another form of forward sale agreement, which we refer to as a “non-contingent forward transaction,” our obligation to sell and the applicable forward purchaser’s obligation to purchase shares of our common stock underlying such forward sale agreement at